O

OrbiMed Advisors

145 employees

OrbiMed is a healthcare-dedicated investment firm focusing on biopharmaceuticals for medical devices and diagnostics.

Investor insights

Countries invested in

united states8
israel2

Sectors invested in

Biotechnology376
Health Care313
Medical152
Therapeutics147
Pharmaceutical138
Biopharma76
Medical Device76
Life Science61
Health Diagnostics45
Manufacturing33
Clinical Trials26
Oncology24
Genetics23
Wellness21
Neuroscience14
Pharmaceuticals13
biotechnology12
Information Technology12
Software12
Hospital11

Funding rounds participated in

$4M sweet spot round size

Most of their 536 investments are in rounds between $23M and $75M

Investor type

Private Equity Firm

Basic info

Industry

investment management

Sectors

Angel Investment
Biotechnology
Fund Management
Financial Services
Health Care
Healthcare
Investment Management

Date founded

1989

Investments made

R

ReCode Therapeutics raised $50M on September 19, 2023

Investors: Sanofi Ventures, Solasta Ventures, Vida Ventures, LLC, Leaps by Bayer, Osage University Partners (OUP), MPM Capital and OrbiMed Advisors

S

Star Therapeutics raised $90M on September 5, 2023

Investors: Qatar Investment Authority, Westlake Village BioPartners®, Sofinnova Ventures, Russia technology fund, Redmile Group, Soleus Capital Management, L.P., New Leaf Venture Partners, NYBC Ventures, RA Capital Management, L.P. and OrbiMed Advisors

F

Fore Biotherapeutics raised $75M on August 23, 2023

Investors: Medicxi, S.R. One Ltd, 3B Future Health Fund, Wellington Management, HBM Partners AG and OrbiMed Advisors

V

Valneva raised $50M on August 17, 2023

Investors: OrbiMed Advisors

V

Vicore Pharma AB raised $46M on June 9, 2023

Investors: Suvretta Capital Management LLC, SEB, AP3 - Third Swedish National Pension Fund, HealthCap, Swedbank Robur and OrbiMed Advisors

U

Undisclosed raised $200M on June 8, 2023

Investors: TCG X, Omega Funds, Samsara BioCapital, Enavate Sciences, Decheng Capital, Wellington Management and OrbiMed Advisors

I

InspireMD raised $114M on May 15, 2023

Investors: Velan Capital, LifeSci Capital, LLC, Soleus Capital Management, L.P., Marshall Wace and OrbiMed Advisors

M

Magenta Medical Ltd. raised $55M on May 3, 2023

Investors: ALIVE Israel HealthTech Fund, Pitango Venture Capital and OrbiMed Advisors

C

Convergent Therapeutics, Inc. raised $90M on May 3, 2023

Investors: The Invus Group, RA Capital Management, L.P. and OrbiMed Advisors

A

Aer Therapeutics, Inc. raised $36M on April 13, 2023

Investors: Canaan and OrbiMed Advisors

FAQ